Collectively, our findings not only uncover a novel function of MyoD in controlling systemic energy homeostasis through the muscle-derived lipokine DLPC but also suggest that the DLPC might have clinical potential for treating obesity in humans. The gene discussed is MYOD1; the disease is obesity due to melanocortin 4 receptor deficiency.